TC
REGN icon

Torno Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Torno Capital’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-36,000
Closed -$37.8M – 288
2024
Q2 		$37.8M Buy
36,000
+14,300
+66% +$13.9M 1.77% 16
2024
Q1 		$20.9M Buy
21,700
+20,700
+2,070% +$19.7M 1.34% 22
2023
Q4 		$878K Buy
+1,000
New +$823K 0.18% 89

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Torno Capital's REGN Position: Q3 2024 in Review

Torno Capital sold out of Regeneron Pharmaceuticals (REGN) in Q3 2024, closing a stake of 36,000 shares — an estimated $37.8M sold.

Torno Capital first reported a position in REGN in Q4 2023 and held it in 3 quarters. The position peaked at $37.8M in Q2 2024. 1,391 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • Torno Capital reported no remaining Regeneron Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Torno Capital sold 36,000 Regeneron Pharmaceuticals shares in Q3 2024, an estimated $37.8M.
  • Torno Capital first reported a position in Regeneron Pharmaceuticals in Q4 2023 and held it in 3 quarters.
  • Torno Capital's Regeneron Pharmaceuticals position peaked at $37.8M in Q2 2024.
  • 1,391 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Torno Capital's 13F filing for Q3 2024, filed 13 Nov 2024.